In summary, we demonstrated that WDR26 is overexpressed in highly malignant breast cancer cells and patient samples, and upregulated WDR26 overactivates the Gβγ-mediated PI3K/AKT pathway downstream of multiple GPCRs, promoting breast cancer cell growth, migration and invasion. The gene discussed is AKT1; the disease is breast carcinoma.